Related Experiment Video
Updated: May 12, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
Published on: February 3, 2012
Functional analyses of recombinant mouse hepcidin-1 in cell culture and animal model
Yaghoub Yazdani1, Neda Keyhanvar, Hamid Reza Kalhor
1Infectious Diseases Research Center and Laboratory Science Research Center, Golestan University of Medical Sciences, Gorgan, Iran. yazdani@goums.ac.ir
Abstract:
Hepcidin is a peptide hormone that plays an important role in iron metabolism. We have produced a recombinant mouse hepcidin-1 by using baculovirus expression system. Its expression yield was 25 μg/ml when cell culture media were supplemented with a protease inhibitor cocktail. The recombinant mouse hepcidin-1 and synthetic human hepcidin-25 had similar effects on reducing ferroportin expression in J774A cell line and in peritoneal macrophages. However, synthetic human hepcidin-25 was more efficient than recombinant mouse hepcidin-1 in reducing iron concentration in blood circulation (p < 0.01).
Insights
Recombinant mouse hepcidin-1 and synthetic human hepcidin-25 both reduce ferroportin expression. However, human hepcidin-25 more effectively lowers blood iron levels, highlighting its potential in iron metabolism regulation.
Area of Science:
- Biochemistry
- Molecular Biology
- Endocrinology
Background:
- Hepcidin is a key peptide hormone regulating iron metabolism.
- Understanding hepcidin's function is crucial for treating iron-related disorders.
- Recombinant hepcidin production offers a tool for studying its biological activity.
Purpose of the Study:
- To produce recombinant mouse hepcidin-1 using a baculovirus system.
- To compare the biological activity of recombinant mouse hepcidin-1 with synthetic human hepcidin-25.
- To evaluate their effects on ferroportin expression and iron concentration.
Main Methods:
- Baculovirus expression system for producing recombinant mouse hepcidin-1.
- Cell culture studies using J774A cell line and peritoneal macrophages.
- Measurement of ferroportin expression and blood iron concentration.
Main Results:
- High yield (25 μg/ml) of recombinant mouse hepcidin-1 achieved with protease inhibitors.
- Both hepcidins similarly reduced ferroportin expression in vitro.
- Synthetic human hepcidin-25 demonstrated superior efficiency in reducing circulating iron levels (p < 0.01).
Conclusions:
- Recombinant mouse hepcidin-1 can be effectively produced.
- Both mouse and human hepcidins impact ferroportin expression.
- Synthetic human hepcidin-25 shows greater potential for clinical applications in iron regulation.

